Diabetes Remission Score Calculator

Estimate preoperative remission likelihood after metabolic surgery using the transparent and widely validated DiaRem score.

Last updated on: March 30, 2026

Calculate Diabetes Remission Score

years
Enter age in years.
%
Enter HbA1c as a percentage.
Choose the preoperative non-insulin diabetes medication profile used by the DiaRem model.
Select yes if insulin is used preoperatively.

Clinical Significance

The DiaRem score is a simple preoperative tool designed to estimate the likelihood of type 2 diabetes remission after metabolic surgery using only age, HbA1c, medication profile, and insulin use.

Although newer models exist, DiaRem remains useful because it is transparent, reproducible, and easy to calculate from routine clinical data.

Score Logic and Example

DiaRem uses four components: age, HbA1c, non-insulin diabetes medications, and insulin use. Scores range from 0 to 22, with lower scores indicating a higher chance of remission.

Age contributes 0 to 3 points, HbA1c contributes 0 to 6 points, specific non-insulin medication use contributes 0 or 3 points, and insulin contributes 0 or 10 points.

Example: age 45 years (1 point), HbA1c 7.8% (4 points), metformin only (0 points), no insulin (0 points) gives a total DiaRem score of 5.

Reference Interpretation

Very High Remission Likelihood: Score 0-2. This is the most favorable DiaRem band and is associated with the highest likelihood of remission after metabolic surgery.
High Remission Likelihood: Score 3-7. This remains a favorable range with relatively strong remission potential compared with higher scores.
Intermediate Remission Likelihood: Score 8-12. This is an intermediate range and should be interpreted alongside procedure type, diabetes duration, and overall clinical context.
Low Remission Likelihood: Score 13-17. This suggests a lower chance of remission compared with lower DiaRem bands.
Very Low Remission Likelihood: Score 18-22. This is the least favorable DiaRem band and is associated with the lowest remission likelihood.

Clinical Notes

DiaRem is best used as a counseling and risk-stratification aid before metabolic surgery. It should not be used alone to approve or deny surgery.

  • Lower DiaRem scores generally indicate a greater chance of diabetes remission.
  • The score was originally developed for preoperative remission prediction after RYGB and has later been externally evaluated in broader bariatric settings.
  • Other models may perform as well or better in some cohorts, but DiaRem remains especially useful because it is simple and transparent.
  • Interpret together with diabetes duration, procedure type, weight trajectory, and the overall clinical context.

This page has been medically reviewed by Dr. Khoulah Attia – PharmD, Immunology Specialist.